Zobrazeno 1 - 10
of 17
pro vyhledávání: '"Michelli RA"'
Autor:
Michelli Ramires Teixeira, Anderson Lucas Alievi, Vitor Rodrigues da Costa, Irina Kerkis, Rodrigo Pinheiro Araldi
Publikováno v:
International Journal of Molecular Sciences, Vol 25, Iss 15, p 8178 (2024)
Mesenchymal stem-cell-derived extracellular vesicles (MSC-EVs) have been increasingly investigated for cancer therapy and drug delivery, and they offer an advanced cell-free therapeutic option. However, their overall effects and efficacy depend on va
Externí odkaz:
https://doaj.org/article/dd64bc4d96d24bb6a0f4b44f1349baea
Autor:
Michelli Ramires Teixeira, Anderson Lucas Alievi, Vitor Rodrigues da Costa, João Rafael Dias Pinto, Rodrigo Pinheiro Araldi
Publikováno v:
Exploration of Neuroscience, Vol 2, Iss 3, Pp 106-122 (2023)
Globally, the incidence of Parkinson’s disease (PD) is increasing faster than other neurodegenerative disorders. Neuropathologically, PD is characterized by the loss of dopaminergic neurons in the substantia nigra pars compacta due to the accumulat
Externí odkaz:
https://doaj.org/article/4d6be0ce9a6f49fba57b69b680645f7b
Autor:
Vitor Rodrigues da Costa, Olívia Fonseca Souza, Michelli Ramires Teixeira, Anderson Lucas Alievi, Hugo Vigerelli, Rodrigo Pinheiro Araldi
Publikováno v:
Exploration of Immunology, Vol 3, Iss 2, Pp 70-81 (2023)
Lung cancer is the leading cause of cancer-related deaths worldwide. The main risk factor for lung cancer is exposure to chemicals present in cigarettes and atmospheric pollutants, which, among other mechanisms, can increase the risk of cancer by ind
Externí odkaz:
https://doaj.org/article/2dda00aaf4a043d2ac6ad84666c1a5fe
Autor:
Rodrigo Pinheiro Araldi, Denis Adrián Delvalle, Vitor Rodrigues da Costa, Anderson Lucas Alievi, Michelli Ramires Teixeira, João Rafael Dias Pinto, Irina Kerkis
Publikováno v:
Cells, Vol 12, Iss 17, p 2144 (2023)
Despite the considerable advancements in oncology, cancer remains one of the leading causes of death worldwide. Drug resistance mechanisms acquired by cancer cells and inefficient drug delivery limit the therapeutic efficacy of available chemotherape
Externí odkaz:
https://doaj.org/article/6a12bc4c2b5b499ca423490cbfd3922e
Autor:
Vieira RA, Zucca Mathes AG, Michelli RA, Ribeiro GH, Haikel RL, Viana CR, Castro Pde T, Uemura G
Publikováno v:
Surgical Infections; 2012 Aug, Vol. 13 Issue 4, p270-275, 6p
Autor:
Fernandes GC; Center of Molecular Diagnosis, Barretos Cancer Hospital, Barretos, São Paulo, Brazil., Michelli RA; Oncogenetics Department, Barretos Cancer Hospital, Barretos, São Paulo, Brazil., Galvão HC; Oncogenetics Department, Barretos Cancer Hospital, Barretos, São Paulo, Brazil., Paula AE; Center of Molecular Diagnosis, Barretos Cancer Hospital, Barretos, São Paulo, Brazil., Pereira R; Institute of Research and Innovation in Health, University of Porto, Porto, Portugal.; Institute of Molecular Pathology and Immunology at the University of Porto (IPATIMUP), Porto, Portugal., Andrade CE; Oncogenetics Department, Barretos Cancer Hospital, Barretos, São Paulo, Brazil., Felicio PS; Molecular Oncology Research Center, Barretos Cancer Hospital, Barretos, São Paulo, Brazil., Souza CP; Oncogenetics Department, Barretos Cancer Hospital, Barretos, São Paulo, Brazil., Mendes DR; Center of Molecular Diagnosis, Barretos Cancer Hospital, Barretos, São Paulo, Brazil., Volc S; Oncogenetics Department, Barretos Cancer Hospital, Barretos, São Paulo, Brazil., Berardinelli GN; Center of Molecular Diagnosis, Barretos Cancer Hospital, Barretos, São Paulo, Brazil., Grasel RS; Oncogenetics Department, Barretos Cancer Hospital, Barretos, São Paulo, Brazil., Sabato CS; Center of Molecular Diagnosis, Barretos Cancer Hospital, Barretos, São Paulo, Brazil., Viana DV; Oncogenetics Department, Barretos Cancer Hospital, Barretos, São Paulo, Brazil., Mauad EC; Oncogenetics Department, Barretos Cancer Hospital, Barretos, São Paulo, Brazil.; Prevention Department, Barretos Cancer Hospital, Barretos, São Paulo, Brazil., Scapulatempo-Neto C; Center of Molecular Diagnosis, Barretos Cancer Hospital, Barretos, São Paulo, Brazil.; Molecular Oncology Research Center, Barretos Cancer Hospital, Barretos, São Paulo, Brazil.; Pathology Department, Barretos Cancer Hospital, Barretos, São Paulo, Brazil., Arun B; MD Anderson Cancer Center, Houston, Texas, USA., Reis RM; Center of Molecular Diagnosis, Barretos Cancer Hospital, Barretos, São Paulo, Brazil.; Oncogenetics Department, Barretos Cancer Hospital, Barretos, São Paulo, Brazil.; Molecular Oncology Research Center, Barretos Cancer Hospital, Barretos, São Paulo, Brazil.; Life and Health Sciences Research Institute (ICVS), Health Sciences School, University of Minho, Braga, Portugal.; ICVS/3B's-PT Government Associate Laboratory, Braga/Guimarães, Portugal., Palmero EI; Center of Molecular Diagnosis, Barretos Cancer Hospital, Barretos, São Paulo, Brazil.; Oncogenetics Department, Barretos Cancer Hospital, Barretos, São Paulo, Brazil.; Molecular Oncology Research Center, Barretos Cancer Hospital, Barretos, São Paulo, Brazil.; Barretos School of Health Sciences, Dr. Paulo Prata-FACISB, São Paulo, Brazil.
Publikováno v:
Oncotarget [Oncotarget] 2016 Dec 06; Vol. 7 (49), pp. 80465-80481.
Autor:
Palmero EI; Centro de Pesquisa em Oncologia Molecular, Hospital de Câncer de Barretos, Barretos, SP, Brazil.; Faculdade de Ciências de Saúde de Barretos, Dr. Paulo Prata - FACISB, Barretos, SP, Brazil.; Departamento de Oncogenética, Hospital de Câncer de Barretos, Barretos, SP, Brazil., Galvão HC; Departamento de Oncogenética, Hospital de Câncer de Barretos, Barretos, SP, Brazil., Fernandes GC; Centro de Pesquisa em Oncologia Molecular, Hospital de Câncer de Barretos, Barretos, SP, Brazil.; Departamento de Oncogenética, Hospital de Câncer de Barretos, Barretos, SP, Brazil., Paula AE; Centro de Pesquisa em Oncologia Molecular, Hospital de Câncer de Barretos, Barretos, SP, Brazil.; Departamento de Oncogenética, Hospital de Câncer de Barretos, Barretos, SP, Brazil., Oliveira JC; Departamento de Oncogenética, Hospital de Câncer de Barretos, Barretos, SP, Brazil., Souza CP; Departamento de Oncogenética, Hospital de Câncer de Barretos, Barretos, SP, Brazil., Andrade CE; Departamento de Oncogenética, Hospital de Câncer de Barretos, Barretos, SP, Brazil., Romagnolo LG; Departamento de Oncogenética, Hospital de Câncer de Barretos, Barretos, SP, Brazil., Volc S; Departamento de Oncogenética, Hospital de Câncer de Barretos, Barretos, SP, Brazil., C Neto M; Departamento de Oncogenética, Hospital de Câncer de Barretos, Barretos, SP, Brazil., Sabato C; Centro de Pesquisa em Oncologia Molecular, Hospital de Câncer de Barretos, Barretos, SP, Brazil.; Departamento de Oncogenética, Hospital de Câncer de Barretos, Barretos, SP, Brazil., Grasel R; Departamento de Oncogenética, Hospital de Câncer de Barretos, Barretos, SP, Brazil., Mauad E; Centro de Pesquisa em Oncologia Molecular, Hospital de Câncer de Barretos, Barretos, SP, Brazil.; Departamento de Oncogenética, Hospital de Câncer de Barretos, Barretos, SP, Brazil., Reis RM; Centro de Pesquisa em Oncologia Molecular, Hospital de Câncer de Barretos, Barretos, SP, Brazil.; Departamento de Oncogenética, Hospital de Câncer de Barretos, Barretos, SP, Brazil.; Life and Health Sciences Research Institute (ICVS), Health Sciences School, University of Minho, Braga, Portugal.; ICVS/3B's-PT Government Associate Laboratory, Braga/Guimarães, Portugal., Michelli RA; Departamento de Oncogenética, Hospital de Câncer de Barretos, Barretos, SP, Brazil.
Publikováno v:
Genetics and molecular biology [Genet Mol Biol] 2016 May 13; Vol. 39 (2), pp. 168-77.
Autor:
Fernandes GC; Molecular Oncology Research Center, Barretos Cancer Hospital, Barretos, Brazil ; Post-Graduate Program in Oncology, Barretos Cancer Hospital, Barretos, Brazil., Michelli RA; Oncogenetics Department, Barretos Cancer Hospital, Barretos, Brazil., Scapulatempo-Neto C; Molecular Oncology Research Center, Barretos Cancer Hospital, Barretos, Brazil ; Post-Graduate Program in Oncology, Barretos Cancer Hospital, Barretos, Brazil ; Pathology Department, Barretos Cancer Hospital, Barretos, Brazil., Palmero EI; Molecular Oncology Research Center, Barretos Cancer Hospital, Barretos, Brazil ; Post-Graduate Program in Oncology, Barretos Cancer Hospital, Barretos, Brazil ; Oncogenetics Department, Barretos Cancer Hospital, Barretos, Brazil ; Barretos School of Health Sciences, Dr. Paulo Prata - FACISB, Barretos, Brazil.
Publikováno v:
Hereditary cancer in clinical practice [Hered Cancer Clin Pract] 2016 Jan 13; Vol. 14, pp. 2. Date of Electronic Publication: 2016 Jan 13 (Print Publication: 2016).
Autor:
Fitarelli-Kiehl M; Post-Graduate Program in Genetics and Molecular Biology, Universidade Federal do Rio Grande do Sul (UFRGS), Porto Alegre, Rio Grande do Sul, Brazil, marianakiehl@gmail.com., Giacomazzi J, Santos-Silva P, Graudenz MS, Palmero EI, Michelli RA, Achatz MI, de Toledo Osório CA, de Faria Ferraz VE, Picanço CG, Ashton-Prolla P
Publikováno v:
Familial cancer [Fam Cancer] 2015 Jun; Vol. 14 (2), pp. 333-6.
Autor:
Giacomazzi J; Genomic Medicine Laboratory, Experimental Research Centre, Hospital de Clínicas de Porto Alegre (HCPA), Porto Alegre, Rio Grande do Sul, Brazil; Post-Graduate Program in Medicine: Medical Sciences, Universidade Federal do Rio Grande do Sul (UFRGS), Porto Alegre, Rio Grande do Sul, Brazil., Graudenz MS; Post-Graduate Program in Medicine: Medical Sciences, Universidade Federal do Rio Grande do Sul (UFRGS), Porto Alegre, Rio Grande do Sul, Brazil; Pathology Service, HCPA, Porto Alegre, Rio Grande do Sul, Brazil and Instituto de Patologia, Porto Alegre, Rio Grande do Sul, Brazil., Osorio CA; Pathology Service, Hospital do Câncer AC Camargo (HCACC), São Paulo, São Paulo, Brazil., Koehler-Santos P; Protein and Molecular Analysis Laboratory, Experimental Research Centre, HCPA, Porto Alegre, Rio Grande do Sul, Brazil., Palmero EI; Molecular Oncology Research Centre, Hospital do Câncer de Barretos, Barretos, São Paulo, Brazil., Zagonel-Oliveira M; National Institute of Populational Medical Genetics (INAGEMP), UFRGS, Porto Alegre, Rio Grande do Sul, Brazil., Michelli RA; Molecular Oncology Research Centre, Hospital do Câncer de Barretos, Barretos, São Paulo, Brazil., Scapulatempo Neto C; Molecular Oncology Research Centre, Hospital do Câncer de Barretos, Barretos, São Paulo, Brazil., Fernandes GC; Molecular Oncology Research Centre, Hospital do Câncer de Barretos, Barretos, São Paulo, Brazil., Achatz MI; Oncogenetics Department, HCACC, São Paulo, São Paulo, Brazil., Martel-Planche G; International Agency for Research on Cancer (IARC), Lyon, Rhone, France., Soares FA; Pathology Service, Hospital do Câncer AC Camargo (HCACC), São Paulo, São Paulo, Brazil., Caleffi M; Hospital Moinhos de Vento, Porto Alegre, Rio Grande do Sul, Brazil., Goldim JR; Bioethics Research Laboratory, HCPA, Porto Alegre, Rio Grande do Sul, Brazil., Hainaut P; International Agency for Research on Cancer (IARC), Lyon, Rhone, France; International Prevention Research Institute, Lyon, Rhone, France., Camey SA; Department of Statistics, Institute of Mathematics, UFRGS, Porto Alegre, Rio Grande do Sul, Brazil., Ashton-Prolla P; Genomic Medicine Laboratory, Experimental Research Centre, Hospital de Clínicas de Porto Alegre (HCPA), Porto Alegre, Rio Grande do Sul, Brazil; Post-Graduate Program in Medicine: Medical Sciences, Universidade Federal do Rio Grande do Sul (UFRGS), Porto Alegre, Rio Grande do Sul, Brazil; National Institute of Populational Medical Genetics (INAGEMP), UFRGS, Porto Alegre, Rio Grande do Sul, Brazil; Post-Graduate Program in Genetics and Molecular Biology, UFRGS, Porto Alegre, Rio Grande do Sul, Brazil.
Publikováno v:
PloS one [PLoS One] 2014 Jun 17; Vol. 9 (6), pp. e99893. Date of Electronic Publication: 2014 Jun 17 (Print Publication: 2014).